Credit Suisse »

Blueprint Medicines shares owned by Credit Suisse

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Credit Suisse from 13F filings

Historical chart of Credit Suisse investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Credit Suisse

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.3M 68k 92.24
2023-09-30 $3.5M 69k 50.22
2023-06-30 $4.8M 76k 63.20
2023-03-31 $2.8M 63k 44.99
2022-12-31 $2.6M 60k 43.81
2022-09-30 $3.9M 58k 65.93
2022-06-30 $2.8M 56k 50.52
2022-03-31 $3.7M 58k 63.84
2021-12-31 $5.6M 53k 107.07
2021-09-30 $5.5M 53k 102.80
2021-06-30 $4.3M 49k 87.90
2021-03-31 $6.5M 52k 125.00
2020-12-31 $9.3M 83k 111.88
2020-09-30 $5.6M 61k 92.44
2020-06-30 $6.1M 78k 77.99
2020-03-31 $2.4M 42k 58.46
2019-12-31 $11M 140k 80.13
2019-09-30 $2.8M 38k 73.40
2019-06-30 $2.9M 30k 94.33
2019-03-31 $3.4M 42k 80.05
2018-12-31 $3.1M 57k 53.97
2018-09-30 $4.0M 51k 78.05
2018-06-30 $2.8M 44k 63.49
2018-03-31 $0 49k 0.00
2017-12-31 $2.7M 36k 75.49
2017-09-30 $3.2M 46k 69.67
2017-06-30 $1.8M 35k 50.67
2017-03-31 $1.6M 40k 40.19
2016-12-31 $628k 31k 20.00
2016-09-30 $583k 20k 29.62
2016-06-30 $519k 26k 20.29